MDVN

Medivation, Inc. News Headlines

$104.13
*  
4.21
3.89%
Get MDVN Alerts
*Delayed - data as of Dec. 22, 2014 11:52 ET  -  Find a broker to begin trading MDVN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    MDVN Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
AMAG Up on Roughly $1B deal with Lumara to Widen Portfolio - Analyst Blog
9/30/2014 4:10:00 PM - Zacks.com


Regado Trims Workforce, Revamps Strategy on Trial Halt - Analyst Blog
9/30/2014 3:30:00 PM - Zacks.com


Agios to Present Data on AG-120 in November, Shares Rises - Analyst Blog
9/29/2014 4:30:00 PM - Zacks.com


Gilead's HCV Combo Drug Harvoni Secures CHMP Backing - Analyst Blog
9/29/2014 4:20:00 PM - Zacks.com


Nektar/AstraZeneca's Moventig a Step Closer to EU Approval - Analyst Blog
9/29/2014 4:10:00 PM - Zacks.com


Stocks Fight Off Predictable Weakness, But Expect More Downside
9/29/2014 4:05:00 AM - Seeking Alpha


Prostate Cancer Incidence Is the Highest in These 5 States
9/28/2014 10:47:02 AM - Motley Fool


Alnylam Starts New Study on Cardiac Amyloidosis Patients - Analyst Blog
9/26/2014 4:10:00 PM - Zacks.com


MannKind and Sanofi Complete Afrezza Collaboration Deal - Analyst Blog
9/26/2014 3:45:00 PM - Zacks.com


Gilead's HIV Drugs Tybost and Vitekta Get FDA Clearance - Analyst Blog
9/26/2014 3:30:00 PM - Zacks.com


Acorda Skyrockets on $525M Civitas Therapeutics Deal - Analyst Blog
9/25/2014 4:47:00 PM - Zacks.com


Gilead Scores with TAF-based HIV Regimen, Shares Up - Analyst Blog
9/25/2014 4:20:00 PM - Zacks.com


Novavax's Influenza Vaccine Study Shows Adjuvant Efficiency - Analyst Blog
9/24/2014 5:10:00 PM - Zacks.com


Gilead (GILD) Seeks Japanese Approval for HCV Combo Drug - Analyst Blog
9/24/2014 5:00:00 PM - Zacks.com


Celgene's Otezla Label Expanded to Include Plaque Psoriasis - Analyst Blog
9/24/2014 4:30:00 PM - Zacks.com


First Week of November 22nd Options Trading For Medivation (MDVN)
9/24/2014 11:25:30 AM - BNK Invest


Medivation: Significant Upside Potential
9/24/2014 10:30:00 AM - Seeking Alpha


Amgen Files Blinatumomab Marketing Application in U.S. - Analyst Blog
9/23/2014 4:55:00 PM - Zacks.com


Cramer's Lightning Round - Don't Go Near Transocean (9/22/14)
9/23/2014 5:45:00 AM - Seeking Alpha


Gilead's (GILD) Zydelig Gets EU Clearance for Blood Cancer - Analyst Blog
9/22/2014 4:20:00 PM - Zacks.com


Alnylam (ALNY) to File Clinical Trial Application for ALN-CC5 - Analyst Blog
9/18/2014 4:10:00 PM - Zacks.com


Biotech Stock Roundup: Avanir Soars on Phase II Data, Orexigen's Contrave Approved - Analyst Blog
9/17/2014 2:00:00 PM - Zacks.com


Is There Further Upside In Medivation?
9/16/2014 8:27:00 AM - Seeking Alpha


Alnylam Expands Pipeline with Preeclampsia Drug ALN-AGT - Analyst Blog
9/15/2014 6:00:00 PM - Zacks.com


Tokai Pharmaceuticals IPO: Lack Of Product Diversity Should Leave Investors Cautious
9/15/2014 8:41:00 AM - Seeking Alpha